Volume: November 2023, Issue 1

Dec 1, 2023 | Hot Topics

AARS Blog News

  • Cabtreo™ (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) topical gel approved for the treatment of acne vulgaris.
  • UK regulatory agency places new restrictions on isotretinoin prescribing.
  • FDA approves Cosentyx for treatment of hidradenitis suppurativa

New Medical Research

  • Combination of fractional microneedling radiofrequency and ablative fractional laser versus ablative fractional laser alone for acne and acne scars.
  • Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.
  • Evaluation of DermSat-7 for assessing treatment satisfaction in patients with acne.
  • 5-Aminolevulinic acid photodynamic therapy using with 560-1200 nm followed by 420-1200 nm broadband light in the treatment of moderate-to-severe acne.
  • An innovative dual-wavelength laser technique for atrophic acne scar management: A pilot study.
  • Acne transcriptomics: Fundamentals of acne pathogenesis and isotretinoin treatment.
  • Evaluation of the effect of oral isotretinoin on the level of serum YKL40 in acne vulgaris patients: A cross-sectional case-control.
  • Photodynamic therapy for severe acne.
  • Topical silymarin cream as a novel therapy versus salicylic acid peels in acne vulgaris: A split-face clinical trial.
  • Efficacy of a multitargeted, salicylic acid-based dermocosmetic cream compared to benzoyl peroxide 5% in acne vulgaris: Results from a randomized study.
  • The efficiency and safety of low-dosage isotretinoin therapy for Chinese acne vulgaris patients.
  • A prospective, multicenter, study of laser-activated gold microparticles for treating patients using concomitant topical retinoids for mild-to-moderate inflammatory acne.
  • Comprehensive assessment of the efficacy and safety of a clay mask in oily and acne skin.
  • Alternating treatment with nonablative fractional laser and radiofrequency microneedling for the treatment of acne scars: A prospective, randomized, split-face study.

Clinical Reviews

  • Long-term maintenance treatment of rosacea: Experts’ opinion.
  • Successful treatment of granulomatous rosacea by JAK inhibitor abrocitinib: A case report.
  • Azithromycin treatment for acne vulgaris: A case report on the risk of clostridioides difficile infection.
  • Case series of demodicosis in acne vulgaris patients.
  • Narrow-band intense pulsed light as treatment for erythematotelangiectatic rosacea: A retrospective study.
  • Seasonal patterns in tetracycline-associated hyperpigmentation among patients with acne vulgaris.
  • Nanomedicine-fortified cosmeceutical serums for the mitigation of psoriasis and acne.

Related Posts

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

Volume: May 2024, Issue 1

Volume: May 2024, Issue 1

AARS News   AARS Call for Grant Applications New Medical Research Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis. The role of vitamins and nutrients in rosacea....

Volume: April 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...

Volume: March 2024, Issue 1

Volume: March 2024, Issue 1

AARS News Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical Research...